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ABSTRACT 
International Journal of Exercise Science 6(2) : 106-113, 2013. The MTI accelerometer 
is highly regarded as a reliable means to measure physical activity in children (Trost et. al., 1998); 
however, it is not always a practical instrument to use. Pedometers offer an alternative method of 
activity measurement and are often more practical. PURPOSE: To validate Omron™ pedometer 
(steps/day) against MTI accelerometer (counts /day and moderate to vigorous physical activity 
(MVPA) min/day) for children. METHODS: 190 children (88 males, 102 females, 8.7±2.1 yrs, 
76.9±27.5 BMI %tile) wore an MTI accelerometer and Omron™ pedometer attached to the same 
belt for 3.9±2.2 days. MVPA was defined as movement ≥4 METs (Troiano et al., 2008). A Pearson 
correlation coefficient was used to determine validity coefficients between Omron™ steps/day 
and MTI accelerometer MVPA min/day and counts/day. A stepwise regression was used to 
predict MVPA using Omron steps/day, sex, and age with 488 days of data. Cross-validation and 
paired t-tests were used to determine differences from predicted MVPA and actual MVPA. 
RESULTS: The correlations between Omron™ steps/day with both MTI counts/day and MTI 
MVPA min/day were r=0.79, p<0.05 and r=0.74, p<0.05 respectively. The model generated from 
the multiple regression equation accounted for 67% of the variance (r2 = 0.6689, SEE = 24.5) in 
MVPA,  MVPA = 67.99 + 0.0068(steps/day) + -7.531(age in years) + 5.559(sex). CONCLUSION: 
Our validation correlations between the Omron™ pedometer and MTI accelerometer were 
acceptable  The results indicate that the Omron pedometer can be used to estimate MVPA 
minutes and could serve as a useful alternative to accelerometry for those with limited resources 
or in practical situations. 
 




An increasingly high percentage of today’s 
youth are not meeting the current physical 
activity (PA) guidelines that highlight the 
importance of maintaining a physically 
active lifestyle. Physical inactivity is 
associated with many health disparities 
including an increasingly high percentage 
of overweight and obese children (23, 21). 
Physical activity is recommended to 
improve health and to reduce the risk of 
several diseases including cardiovascular 
disease, type II diabetes, osteoporosis, 
obesity, and certain types of cancer (5). 
Studies have shown that the onset of 
obesity (21), cardiovascular disease (4), and 
various chronic disease risk factors (8) have 
origins early in life. Hence, there is a 
definite need to understand the factors that 
influence physical activity among children 
and adolescents.   
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Identifying an affordable, reliable, valid, 
and feasible tool to measure physical 
activity among children has become a 
necessity in the effort to increase physical 
activity among children (32). 
Accelerometers are one of the most 
commonly used methods for assessing free 
living physical activity (7, 36) and they have 
been validated as a reliable means to 
estimate energy expenditure during 
activities of daily living in children (9, 11, 
19). However, the affordability of many 
accelerometers ($200 to $500 per unit) 
makes it impractical for large-scale 
applications and their use requires technical 
expertise along with additional software for 
processing (36). The use of pedometers has 
gained popularity as motivational devices 
for increasing physical activity levels (31, 
14). These devices are often both affordable 
($5 to $100 per unit) and relatively easy to 
use. Most electronic pedometers in today’s 
market contain a horizontal, spring-
suspended lever arm that deflects with 
vertical acceleration of the hips during 
ambulation. Each step opens and closes an 
electrical circuit and an accumulated step 
count is displayed digitally (31).   
 
A review of adults (35) compared the 
validity of the Actigraph accelerometer and 
Omron™ pedometer in free-living 
conditions and found a 25.8% error when 
comparing steps to steps. A previous study 
(14) in children examined the difference 
between Omron steps/day and Actigraph 
steps/day and found a comparable 
measure of mean steps (M absolute delta = 
431). Another study in children compared a 
pedometer to the Actigraph accelerometer 
to determine an average daily step count 
comparable to the 60 minutes of moderate- 
to-vigorous physical activity (MVPA) (9). 
However, no studies have attempted to 
formulate an equation that predicts an 
estimated amount of minutes in MVPA 
using pedometer step counts. 
 
This study aims to test the concurrent 
validity of the Omron™ pedometer and 
Actigraph accelerometer and then 
determine if pedometer steps per day can 
be used to predict moderate to vigorous 
physical activity (min/day)(MVPA) for 
children. The study will produce a 
prediction equation that uses Omron 
pedometer steps per day to estimate MVPA 
from Actigraph accelerometry counts 





The data used in this study were obtained 
from participants in ongoing studies that 
were also measuring physical activity by 
use of the Actigraph accelerometer. These 
studies included a family based weight loss 
program, an elementary school physical 
education program, and a classroom 
physical activity intervention program. 
Data were collected from 190 children (age 
= 8.7 ± 2.1 years, BMI%tile = 76.9 ± 27.5) 
including 78 normal weight, 42 overweight, 
and 70 obese children (88 males, 102 
females). BMI percentiles were determined 
by the method established by Center for 
Disease Control and Prevention (CDC, 
Atlanta, GA, 2012). Written consent was 
provided by the parents/guardians and 
assent was documented by the child prior 
to participation and the study was 
approved by the University of Nebraska 
Kearney Institutional Review Board. 
 
Protocol 
Devices: Accelerometers are electronic 
devices that measure accelerations 
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produced by body movement by using 
piezoelectric transducers and 
microprocessors that convert recorded 
accelerations to a quantifiable digital 
signals referred to as “counts”. Counts can 
be entered into independently developed 
prediction equations for estimation of time 
spent in light, moderate, and vigorous 
physical activity (29). Most accelerometers 
have the ability to store data up to 30 days 
and be downloaded to a computer for 
processing (40).  
 
The Actigraph accelerometer (MTI Model 
7164; Actigraph, Fort Walton Beach, FL) has 
been used in a number of studies involving 
children (9, 36). It is a uniaxial 
accelerometer that measures acceleration in 
the vertical plane; it is small (5.08 X 4.06 X 
1.52 cm), light (42.52 g), and unobtrusive. 
Its acceleration signal is filtered by an 
analog band-pass filter and digitized by an 
8-bit A/D converter at a sampling rate of 10 
samples per second (2, 16).   
 
A review by Tudor-Locke et al (35), found 
that multiple studies have validated a 
variety of pedometers against 
accelerometers including the Actigraph 
model. Omron Healthcare (Kyoko City, 
Japan) developed an electronic pedometer 
that is marketed to be worn at different 
sites on and off the body. The HJ-720ITC 
model features dual sensors, thus offering 
mid-back, right pocket, and left pocket 
positions as well as an off-the-body 
backpack wearing option. 
 
Program: Participants wore a MTI 
accelerometer (GT1M; Actigraph, Fort 
Walton Beach, FL)  and Omron™ 
pedometer(Model HJ-720ITC, Omron 
Healthcare, Kyoko City, Japan) attached to 
the same belt for 3.9 ± 2.2 days. A wear time 
validation was performed using a SAS 
program to exclude insufficient data. For 
data to be included, both devices had to be 
worn for a minimum of 8 hours per day 
(minutes having zero accelerometer counts 
indicated non-wear time) between 7am and 
9pm for at least 2 separate days over the 
course of one week’s time (30). The 
accelerometers were attached snugly to the 
hip at the waist line directly above the 
patella. This location was based on 
instructions given by the accelerometer’s 
producer Manufacturing Technology, Inc 
(Pensacola, FL). The pedometer was placed 
in a pouch to ensure that it remained 
securely attached to the same belt that held 
the accelerometer. Both the accelerometer 
and the pedometer were worn on the same 
hip at the same time.  
 
All accelerometers were programmed to 
start collecting data on midnight of the day 
following delivery. Both devices were 
synced using the same computer clock. 
Upon return of the devices, data were 
downloaded and data from the MTI 
accelerometers were analyzed with the 
Actigraph software version 5.5. Data were 
collected in 15 second epochs based on 
previous research showing children tend to 
perform physical activity in short bursts 
rather than in prolonged bouts (1). The 
counts registered by the accelerometer were 
inserted into an equation developed by 
Trost et al. (28) that converts counts to 
METs specifically for children [METs = -
2.23 + 0.0008 (counts per minute) + 0.08 
(body mass (kg)]. MVPA was then defined 
as any movement ≥4 METs (26). The 
Omron™ pedometer data was downloaded 
using Omron™ software version 1.3 for 
total steps per day. 
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Statistical Analysis 
Daily minutes of MVPA and counts per day 
from the accelerometers and steps per day 
from the pedometers were analyzed using 
by the Statistical Analysis System (SAS) 
program developed by SAS Institute Inc. 
(Cary, NC). The total number of valid days 
for all 190 participants with each day 
containing pedometer steps, accelerometer 
counts, and MVPA (n=732 days) were 
randomly divided into two groups: 66% of 
the days were assigned to a validation 
group (n=488) and 33% of the days were 
assigned a cross-validation group (n=244). 
Using the validation group data, partial 
Pearson correlation coefficients, adjusting 
for age were calculated  between Omron™ 
steps/day and MTI accelerometer MVPA 
min/day and counts/day. A stepwise 
regression analysis was used to predict 
MVPA (min/day) from Omron™ steps per 
day, sex, and age. Sex and age were used 
because the currently recommended daily 
step counts for children are determined by 
sex and age (37). Sex is entered into the 
equation as 1 for males and 0 for females.  
The data from the cross-validation group 
was then used to cross-validate the 
prediction equation. Paired t-tests were 
used to determine differences between 
predicted MVPA and actual MVPA from 
the accelerometer for each individual day. 
Bland Altman plots were used to examine 
the individual agreement across the range 
of physical activity levels. In these plots, the 
difference between estimates (criterion-
comparison) was plotted on the y-axis 
while the mean of the estimates ((criterion + 
comparison)/2) was plotted on the x-axis. 
Confidence intervals defining the limits of 
agreement were established as ± 2 standard 





Descriptive characteristics including age, 
BMI (kg·m-2), BMI percentile, and activity 
level can be found in Table 1. 
 
Table 1. Descriptive characteristics including 




Age (yrs) 8.7 ±	 2.1 
BMI (kg/m2) 20.4 ±	 4.9 
BMI Percentile 76.9 ±	 27.5 
Steps/day 8701 ±	 4271 
MVPA min/day 62.9 ±	 44.3 
Counts/day 357386 ±	 185627 
Average wear time 
(days) 
3.9 ±	 2.2 
BMI Percentile based on Centers for Disease Control 
child and adolescent BMI model calculated with age 
and gender, Steps/day from Omron™ pedometer, 
MVPA: Moderate to vigorous physical activity from 
MTI accelerometer Counts/day, MVPA and 
Counts/day from MTI accelerometer 
 
Pearson correlation coefficients between 
Omron™ steps/day and MTI MVPA 
min/day and counts/day were r = 0.76 
(p<0.0001) and r = 0.79 (p<0.0001) 
respectively.  
 
Multiple regressions using validation 
groups produced a prediction equation to 
estimate MVPA using steps per day, age, 
and sex. This model accounted for 67% of 
variance in MVPA (R2 = 0.6689, SEE = 24.5 
min/day).  
 
MVPA min/day = 67.99 + 
0.0068(steps/day) + -7.531(age in years) + 
5.559(sex) 
 
The data from the cross validation group 
was then entered into the prediction 
equation and results were compared to 
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MVPA from actual recorded MTI 
accelerometer data. The average MVPA 
from accelerometry was found to be 67.02 ± 
47.54 min/day and the predicted MVPA 
generated from our prediction equation 
was calculated to be 63.69 ± 35.73 min/day 
with a difference of 3.32 ± 28.26 min/day. 
Bland-Altman plot was used to examine the 
distribution of error for estimation of time 
spent in PA (Figure 1). The patterns did not 
exhibit any systemic form of bias, but the 
relationships were tighter when the 
minutes of MVPA were lower. The graph 
also shows that as the minutes of MVPA 
increased there was considerable  
variability, in some cases as much as a 50 
min differential from the mean.  The overall 




Figure 1. Bland-Altman plot comparing accuracy of 
prediction across the range of scores for the Omron 
TM pedometer and MTI accelerometer (difference = 
estimated predicted). 
 
This plot is displaying the difference 
between each method of calculating MVPA 
(MTI accelerometer and Omron pedometer) 
on the y axis and the mean of each method 




One behavioral mechanism for encouraging 
children to be physically active is 
measurement of daily physical activity 
using a reliable and affordable method (25). 
Due to the limitations of self-reported 
physical activity, direct observation, and 
accelerometry, pedometer based measures 
appear to be a reliable and affordable 
technique to quantify physical activity in 
children. A study by Tudor-Locke et al. (35) 
on the convergent validity of pedometers 
and accelerometers (specifically uniaxial 
accelerometers) that included a wide array 
of devices found a median correlation value 
of r = 0.86 with the range varying from 
nonsignificant to r = 0.99 depending on the 
instruments used, epoch length, and the 
manner in which the outputs are expressed. 
Our results suggest that within limitations, 
Omron™ pedometers can provide a rough 
estimate of daily physical activity in 
children and predict MVPA compared to 
the widely validated MTI accelerometer. 
The large standard deviations and SEE 
could be related to the data being collected 
from a group of relatively inactive children 
in a weight loss intervention and a 
generalized mix of elementary school aged 
children.  
 
Other studies found similar results when 
comparing pedometers and accelerometers 
in both adults and children. Kilanowski et 
al. (14) found a high correlation (r = 0.98, p 
< 0.001) during the recreation time of 10 
children aged 7-12 yrs and a correlation of r 
= 0.50, p = 0.41 during their classroom time. 
Another study comparing the MTI 
counts/day and the Yamax Digiwalker 500 
steps/day during free-living activities 
found a correlation of r = 0.84 in adults (19). 
Our evidence, combined with evidence 
from previous studies, indicates that the 
output of pedometers is correlated with the 
output of accelerometers in free-living 
conditions when both devices’ output is 
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expressed as raw data (i.e. steps/day, 
counts/day, etc.) (30). However, our study 
goes one step further to estimate minutes of 
moderate-to-vigorous physical activity 
based on step counts. 
 
The findings of this study indicate that the 
Omron pedometer has concurrent validity 
with the Actigraph accelerometer when 
compared to studies of a similar nature (r2 = 
0.6689, SEE = 24.5). This helps to strengthen 
the prediction equation used to predict 
MVPA using steps/day. Currently the most 
practical and quantitative method of 
measuring MVPA is by use of research 
grade accelerometers that are often 
expensive and unavailable to the general 
public. Organizations such as ACSM and 
the CDC have produced physical activity 
recommendations for the general public 
based on minutes of moderate-to- vigorous 
physical activity. Therefore, having an 
equation that can predict MVPA using 
widely available pedometers may result in 
better application of step data to determine 
levels of physical activity.  
 
The outliers in the data indicated that in a 
few cases when a particular child achieved 
substantially more or less estimated daily 
MVPA than the average daily MVPA found 
in this study, the equation may incorrectly 
predict a child’s MVPA. However, the 
outliers were included in the Pearson 
correlations so therefore the equation is still 
noteworthy. Future studies should examine 
these extreme cases further. It should also 
be noted that the authors of this paper 
associated a higher daily step count to more 
daily MVPA, not more wear time.  
 
This study had certain limitations. All the 
participants used in this study were from a 
rural Midwestern location (population: 
30,000). The Omron™ pedometer used in 
this study was not cross-validated against 
any other acceptable means of 
measurement. Another limitation of the 
current study is the inability of either step 
counters or accelerometers to account for 
non-ambulatory movements such as 
swimming and cycling (18). The newest 
version of the Actigraph accelerometer was 
not used in this study, however, a previous 
study found no significant difference 
between the GT1M, GT3X, and GT3X+ 
when worn by children in free-living 
conditions (38). Each individual 
accelerometer and pedometer was not 
cross-checked to be sure each instrument 
was performing similarly. Future studies 
should analyze this pedometer against 
other measurements of energy expenditure 
including indirect calorimetry, heart 
rate/breathing rate, and VO2 levels to 
obtain a better validation. Strengths of this 
study included a large sample size, an 
average wear time of at least two full days 
for all participants, and the ability to sync 
the devices by time to ensure each is 
measuring the same instances.  
 
Our data suggests that MVPA min/day can 
be estimated, with some variability, with 
the use of a cost efficient, research grade 
pedometer in children. With the ever 
changing technological advancements 
making better and cheaper products in 
today’s society, the use of activity monitors 
(primarily pedometers) has become very 
popular for use in interventions and weight 
loss programs for children (3). The ability to 
estimate MVPA min/day from steps/day 
can lead to better physical activity 
assessment and expanded data collection 
possibilities in large populations.  More 
importantly, our findings support 
widespread use of pedometry and the 
VALIDATION OF OMRON TM PEDOMETERS FOR CHILDREN 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
112 
ability to convert the data they record (steps 
per day) into a more meaningful unit of 
measure (estimated MVPA) for those with 
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